Literature DB >> 10510435

Ser203 as well as Ser204 and Ser207 in fifth transmembrane domain of the human beta2-adrenoceptor contributes to agonist binding and receptor activation.

T Sato1, H Kobayashi, T Nagao, H Kurose.   

Abstract

We examined the contribution of Ser203 of the human beta2-adrenoceptor (beta2-AR) to the interaction with isoprenaline. The affinity of (-)-isoprenaline was reduced by substitution of an alanine for Ser203, as well as for Ser204 and Ser207. An (-)-isoprenaline derivative with only one hydroxyl group, at the meta-position, showed reduced affinity for wild-type beta2-AR and S207A-beta2-AR and even lower affinities for S203A-beta2-AR and S204A-beta2-AR. By contrast, an (-)-isoprenaline derivative with only a para-hydroxyl group showed reduced affinity for wild-type beta2-AR but the serine to alanine mutations did not cause further decreases. The EC50 value for cyclic AMP generation in response to (-)-isoprenaline was increased, by about 120 fold, for each alanine-substituted beta2-AR mutant. These results suggest that Ser203 of the human beta2-AR is important for both ligand binding and receptor activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510435      PMCID: PMC1571654          DOI: 10.1038/sj.bjp.0702813

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  pEF-BOS, a powerful mammalian expression vector.

Authors:  S Mizushima; S Nagata
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

2.  Identification of residues required for ligand binding to the beta-adrenergic receptor.

Authors:  C D Strader; I S Sigal; R B Register; M R Candelore; E Rands; R A Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.

Authors:  C D Wang; M A Buck; C M Fraser
Journal:  Mol Pharmacol       Date:  1991-08       Impact factor: 4.436

4.  Amino acids of the alpha1B-adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypes.

Authors:  A Cavalli; F Fanelli; C Taddei; P G De Benedetti; S Cotecchia
Journal:  FEBS Lett       Date:  1996-12-09       Impact factor: 4.124

5.  The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005.

Authors:  H Kikkawa; M Isogaya; T Nagao; H Kurose
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

6.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor.

Authors:  C D Strader; M R Candelore; W S Hill; I S Sigal; R A Dixon
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

7.  Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation.

Authors:  N J Pollock; A M Manelli; C W Hutchins; M E Steffey; R G MacKenzie; D E Frail
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

8.  The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation.

Authors:  J Hwa; D M Perez
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

9.  Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors.

Authors:  B A Cox; R A Henningsen; A Spanoyannis; R L Neve; K A Neve
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

10.  Structural features required for ligand binding to the beta-adrenergic receptor.

Authors:  R A Dixon; I S Sigal; M R Candelore; R B Register; W Scattergood; E Rands; C D Strader
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  21 in total

1.  The essential role for aromatic cluster in the β3 adrenergic receptor.

Authors:  Hai-yan Cai; Zhi-jian Xu; Jie Tang; Ying Sun; Kai-xian Chen; He-yao Wang; Wei-liang Zhu
Journal:  Acta Pharmacol Sin       Date:  2012-06-25       Impact factor: 6.150

2.  Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptor.

Authors:  Santiago Vilar; Joel Karpiak; Stefano Costanzi
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

3.  Differences in allosteric communication pipelines in the inactive and active states of a GPCR.

Authors:  Supriyo Bhattacharya; Nagarajan Vaidehi
Journal:  Biophys J       Date:  2014-07-15       Impact factor: 4.033

4.  Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.

Authors:  Yanyan Zhu; Yuan Yuan; Xiuchan Xiao; Liyun Zhang; Yanzhi Guo; Xuemei Pu
Journal:  J Mol Model       Date:  2014-10-25       Impact factor: 1.810

5.  A comparison of agonist-specific coupling of cloned human alpha(2)-adrenoceptor subtypes.

Authors:  J E Rudling; J Richardson; P D Evans
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor.

Authors:  Juha M Peltonen; Tommi Nyrönen; Siegfried Wurster; Marjo Pihlavisto; Anna-Marja Hoffrén; Anne Marjamäki; Henri Xhaard; Liisa Kanerva; Juha-Matti Savola; Mark S Johnson; Mika Scheinin
Journal:  Br J Pharmacol       Date:  2003-08-18       Impact factor: 8.739

7.  Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.

Authors:  Vsevolod Katritch; Kimberly A Reynolds; Vadim Cherezov; Michael A Hanson; Christopher B Roth; Mark Yeager; Ruben Abagyan
Journal:  J Mol Recognit       Date:  2009 Jul-Aug       Impact factor: 2.137

8.  On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.

Authors:  Stefano Costanzi
Journal:  J Med Chem       Date:  2008-04-29       Impact factor: 7.446

9.  Structure of a beta1-adrenergic G-protein-coupled receptor.

Authors:  Tony Warne; Maria J Serrano-Vega; Jillian G Baker; Rouslan Moukhametzianov; Patricia C Edwards; Richard Henderson; Andrew G W Leslie; Christopher G Tate; Gebhard F X Schertler
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

10.  Agonist-specific coupling of a cloned human alpha1A-adrenoceptor to different second messenger pathways.

Authors:  Joanna Richardson; Heather Chatwin; Akira Hirasawa; Gozoh Tsujimoto; Peter D Evans
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-20       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.